RI Pharma Limited - Period Ending 2014-12-31

Registration number: 06678405

RI Pharma Limited

Annual Report and Unaudited Abbreviated Accounts

for the Period from 1 September 2013 to 31 December 2014

DRP + Co Accountants Limited
Upper Floor
6 St John's Court
Enterprise Park
Swansea
C & C of Swansea
SA6 8QQ

RI Pharma Limited
Contents

Abbreviated Balance Sheet

Notes to the Abbreviated Accounts

2 to 3

RI Pharma Limited
(Registration number: 06678405)
Abbreviated Balance Sheet at 31 December 2014

	Note	31 December 2014 £	31 August 2013 £
Fixed assets
Intangible fixed assets		544,088	424,546
Current assets
Debtors		57,692	885
Cash at bank and in hand		115	285
		57,807	1,170
Creditors: Amounts falling due within one year		(41,274)	(2,436)
Net current assets/(liabilities)		16,533	(1,266)
Total assets less current liabilities		560,621	423,280
Creditors: Amounts falling due after more than one year		(592,899)	(428,037)
Net liabilities		(32,278)	(4,757)
Capital and reserves
Called up share capital	3	2	2
Profit and loss account		(32,280)	(4,759)
Shareholders' deficit		(32,278)	(4,757)

For the year ending 31 December 2014 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime .

Approved by the Board on 30 September 2015 and signed on its behalf by:

.........................................
Mr A Farah
Director

The notes on pages 2 to 3 form an integral part of these financial statements.
Page 1

RI Pharma Limited
Notes to the Abbreviated Accounts for the Period from 1 September 2013 to 31 December 2014
......... continued

1	Accounting policies

Basis of preparation

The full financial statements, from which these abbreviated accounts have been extracted, have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (Effective April 2008).

Going concern

The directors have adopted a going concern basis of accounting.

The company has and will be able to continue its investment in product licences with the continued support from Pharmacare Premium Limited. The loans to date are interest free with no set terms of repayment and Pharmacare has given an undertaking that no repayment is required within one year of the financial accounts to 31st December 2014.

2	Fixed assets

	Intangible assets £	Total £
Cost
At 1 September 2013	424,546	424,546
Additions	119,542	119,542
At 31 December 2014	544,088	544,088
Depreciation
At 31 December 2014	-	-
Net book value
At 31 December 2014	544,088	544,088
At 31 August 2013	424,546	424,546

3	Share capital

Allotted, called up and fully paid shares

	31 December 2014			31 August 2013
		No.	£		No.	£
Ordinary Shares of £1 each		2	2		2	2

Page 2

RI Pharma Limited
Notes to the Abbreviated Accounts for the Period from 1 September 2013 to 31 December 2014
......... continued

Control

Pharmacare Premium Limited (incorporated in Malta) is regarded by the directors as being the company's ultimate parent company.

Page 3